Medibio & Mayo Clinic collaborate on depression technology
Filed with ASX · · 2 pages · English
Earlier from TrivarX
- Appendix 4C - quarterly
- MEB completes heavily oversubscribed institutional placement
- Response to ASX Query
- Medibio enters into an Agreement with Otsuka Pharmaceutical
- Medibio enters agreement with Mayo Clinc
Later from TrivarX
- Medibio Announces ISO 13485 Certification
- Agreement with Striiv to Accelerate Commercialisation
- Medibio Quarterly Update and Cash Flow Report
- MEB signs binding term sheet to acquire Vital Conversations
- Medibio Receives CE Certification
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX